Select Bibliography

Filter by any of these (after searching):

George, Stephen L.

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 8 items

Low-Dose Interleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older With Acute Myeloid Leukemia in First Complete Remission: Cancer and Leukemia Group B Study 9720

Baer, Maria R. , George, Stephen L. , Caligiuri, Michael A. ... - - J Clin Oncol - 2008

Manuscript - Secondary - Primary - Leukemia - CALGB-8461 , CALGB-9720

Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720

Baer, Maria R. , George, Stephen L. , Caligiuri, Michael A. ... - ASCO - J Clin Oncol - 2008

Abstract - Secondary - Primary - Leukemia - CALGB-10201 , CALGB-10502 , CALGB-10503 , CALGB-10603 , CALGB-19808 , CALGB-8525 , CALGB-8923 , CALGB-9022 , CALGB-9222 , CALGB-9420 , CALGB-9621 , CALGB-9720

Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (Alliance) clinical trials

Castillo, Jorge J. , Mulkey, Flora , Geyer, Susan ... - - Am J Hematol - 2016

Manuscript - Secondary-not-in-original - Meta-Analysis - Leukemia - CALGB-9621 , CALGB-9710 , CALGB-10503 , CALGB-19808

Comparison of Reduced-Intensity Hematopoietic Cell Transplantation with Chemotherapy in Patients Aged 60–70 Years with Acute Myeloid Leukemia in First Remission

Farag, Sherif S. , Maharry, Kati , Zhang, Mei-Jie , Pérez, Waleska S. ... - - Biol Blood Marrow Transplant - 2011

Manuscript - Secondary-not-in-original - Comprehensive - Leukemia - CALGB-9720 , CALGB-10201

Recombinant Interleukin-2 in Patients Aged Younger Than 60 Years With Acute Myeloid Leukemia in First Complete Remission

Kolitz, Jonathan E. , George, Stephen L. , Benson, Don M. ... - - Cancer - 2014

Manuscript - Primary - Long-Term-Followup - Leukemia - CALGB-19808

P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808

Kolitz, Jonathan E. , George, Stephen L. , Marcucci, Guido ... - - Blood - 2010

Manuscript - Primary - Primary - Leukemia - CALGB-19808 , CALGB-8461

Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222

Moore, Joseph O. , George, Stephen L. , Dodge, Richard K. ... - - Blood - 2005

Manuscript - Primary - Primary - Leukemia - CALGB-9222

Validation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials

Wang, Xiaofei , Wang, Xiaoyi , Hodgson, Lydia , George, Stephen L. ... - - Oncologist - 2017

Manuscript - Secondary-not-in-original - Primary - Respiratory - Alliance-A151724 , CALGB-8435 , CALGB-8638 , CALGB-8833 , CALGB-8933 , CALGB-9031 , CALGB-30101 , CALGB-30107 , CALGB-30307 , CALGB-30601 , CALGB-39807 , CALGB-9131 , CALGB-9234 , CALGB-9530 , CALGB-9631 , CALGB-9733 , NCCTG-N0021 , NCCTG-N0623